Incessant Launch of Technologically Advanced Products Driving the Genetic Testing Market

2026-08-11 11:42:21 Health and Fitness

1109

Increasing number of successful clinical studies & product launches in the market is likely to offer significant opportunity for genetic testing market to burgeon, says RNCOS.

According to a new research report by RNCOS entitled, ?Global Genetic Testing Market Outlook 2022?, the genetic testing market is very dynamic and is marked by considerable advancement in genetic technologies. Such technological advancements in the genetic testing market are due to the increasing demand for innovative tools and technology that can make the research work easier and faster. Also, various prominent players are also engaged in developing and commercializing new and innovative products.

In this regard, in January 2016, Ambry Genetics launched a new suite of five genetic tests for neuro developmental conditions. Furthermore, in January 2016, the Icahn School of Medicine at Mount Sinai launched a range of new carrier screening tests, NextStep Carrier Screening, which are market leading in terms of breadth and depth of coverage. These new tests include a pan-ethnic carrier screen for 281 diseases, the largest currently available.

Similarly, in July 2016, Great Ormond Street Hospital together with their research partner UCL Institute of Child Health, launched non-invasive prenatal testing services for the GCC area. These services will be offered to hospitals and clinics in Kuwait and the UAE. In another recent development, in July 2016, Newcastle researchers have developed a genetic test providing a rapid diagnosis of mitochondrial disorders to identify the first patients with inherited mutations in a new disease gene.

Early this year, in Feb 2016, Greenville Health System and Selah Genomics planned to expand a partnership founded in May 2015 to develop and commercialize genetic tests, initially for cancer patients. The partnership now includes cardiovascular genetic testing with the commercial launch of a new test which reveals a person?s risk of sudden cardiac death (SCD). Also in the same month, a new test has been launched to detect inherited heart conditions, which affect more than half a million people in the UK. Since advancements and innovations in this sector has seen augmented growth and is expected to continue ahead, the market is expected to continue to grow at the double digit rate of 10.1% for the next six years.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM840.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.